Q3 2025 Novavax Inc Earnings Call Transcript

Nov 6, 2025 / 01:30 PM GMT

Release Date Price: $7.59 (-1.30%)

Transcript 8-K10-Q

Key Points

Positve

Novavax Inc (NVAX) has made significant progress in transforming its business model, focusing on partnerships and R&D innovation.
The company has achieved approximately $1.1 billion in non-diluted cash flow over the past eight quarters, including $800 million from partnerships.
Novavax Inc (NVAX) expanded its partnership with Sanofi to include the use of its MatrixM adjuvant in Sanofi's pandemic flu vaccine candidate.
The company has launched a new early-stage portfolio targeting C. Diff, shingles, RSV combination, and pandemic flu, with exploration into oncology.
Novavax Inc (NVAX) has improved its financial strength by reducing liabilities and operating expenses, and consolidating its Maryland campus footprint for significant cost savings.

Negative

Novavax Inc (NVAX) reported a net loss of $202 million for the third quarter of 2025.
The company's total revenue for Q3 2025 decreased to $70 million from $85 million in the same period of 2024.
There is uncertainty regarding the timing of the Sanofi KIC program's advancement, potentially delaying profitability goals.
The transition of lead commercial activities to Sanofi has resulted in a significant reduction in SG&A expenses, but also indicates a reliance on Sanofi's execution.
The company's path to non-GAAP profitability is contingent on successful development and regulatory approval of partner programs, which introduces external dependencies.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NVAX.OQ - Novavax Inc
Q3 2025 Novavax Inc Earnings Call
Nov 06, 2025 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to Novavax's 3rd quarter 2025 financial results and operational highlights conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the key followed by zero.

After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star and then the digit 1 on your touchtone phone. To withdraw your question, repeat the steps of star and 1. Please note this event is being recorded, and I would now like to turn the conference over to Louis Sanne, Vice President, Investor Relations. Please go ahead, sir.

--------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.